This consent form for the NEXT Medicine Study is designed for individuals with endometrial/uterine cancer or a close family member with this type of cancer. It contains information about the study and the researchers involved, the purpose of the study, what is involved in participating, potential risks and benefits of participating, financial questions and answers related to the study, and who to contact with questions.

The Research Participant's Authorization to Disclose/Release Genetic Information Form for the NEXT (New EXome Technology in Medicine) Medicine Study authorizes the principal investigator of the study to disclose the participant's genetic research results to a specified person in the case of participant death or incapacitation.

This short explanation card defines an inherited mutation and describes the information that parents might find on their child's inherited mutation report.

This document provides answers to frequently asked questions for participants in Personalized Oncology Through High-throughput Sequencing: Michigan Oncology Sequencing Center (MI-ONCOSEQ) Study.